Fibrosis Stage and Metabolic Dysfunction Emerge as Main Mortality Drivers in MASLD
A review of 131 studies presented at BASL 2026 found fibrosis progression and systemic metabolic dysfunction are the leading predictors of death in MASLD.
Oct 23, 2026 · 3 min read
88 views